These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 8230110)
1. 3-(Alkylamino)-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides as powerful inhibitors of insulin release from rat pancreatic B-cells: a new class of potassium channel openers? Pirotte B; de Tullio P; Lebrun P; Antoine MH; Fontaine J; Masereel B; Schynts M; Dupont L; Herchuelz A; Delarge J J Med Chem; 1993 Oct; 36(21):3211-3. PubMed ID: 8230110 [No Abstract] [Full Text] [Related]
2. 3-Alkylamino-4H-pyrido[2,3-e]-1,2,4-thiadiazine 1,1-dioxides structurally related to diazoxide and pinacidil as potassium channel openers acting on vascular smooth muscle cells: design, synthesis, and pharmacological evaluation. Pirotte B; Ouedraogo R; de Tullio P; Khelili S; Somers F; Boverie S; Dupont L; Fontaine J; Damas J; Lebrun P J Med Chem; 2000 Apr; 43(8):1456-66. PubMed ID: 10780901 [TBL] [Abstract][Full Text] [Related]
4. 4H-1,2,4-Pyridothiadiazine 1,1-dioxides and 2,3-dihydro-4H-1,2, 4-pyridothiadiazine 1,1-dioxides chemically related to diazoxide and cyclothiazide as powerful positive allosteric modulators of (R/S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptors: design, synthesis, pharmacology, and structure-activity relationships. Pirotte B; Podona T; Diouf O; de Tullio P; Lebrun P; Dupont L; Somers F; Delarge J; Morain P; Lestage P; Lepagnol J; Spedding M J Med Chem; 1998 Jul; 41(16):2946-59. PubMed ID: 9685234 [TBL] [Abstract][Full Text] [Related]
5. Preparation and pharmacological evaluation of the R- and S-enantiomers of 3-(2-butylamino)-4H- and 3-(3-methyl-2-butylamino)-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxide, two tissue selective ATP-sensitive potassium channel openers. Khelili S; de Tullio P; Lebrun P; Fillet M; Antoine MH; Ouedraogo R; Dupont L; Fontaine J; Felekidis A; Leclerc G; Delarge J; Pirotte B Bioorg Med Chem; 1999 Aug; 7(8):1513-20. PubMed ID: 10482443 [TBL] [Abstract][Full Text] [Related]
10. Toward tissue-selective pancreatic B-cells KATP channel openers belonging to 3-alkylamino-7-halo-4H-1,2,4-benzothiadiazine 1,1-dioxides. de Tullio P; Becker B; Boverie S; Dabrowski M; Wahl P; Antoine MH; Somers F; Sebille S; Ouedraogo R; Hansen JB; Lebrun P; Pirotte B J Med Chem; 2003 Jul; 46(15):3342-53. PubMed ID: 12852765 [TBL] [Abstract][Full Text] [Related]
11. Original 2-alkylamino-6-halogenoquinazolin-4(3H)-ones and K(ATP) channel activity. Somers F; Ouedraogo R; Antoine MH; de Tullio P; Becker B; Fontaine J; Damas J; Dupont L; Rigo B; Delarge J; Lebrun P; Pirotte B J Med Chem; 2001 Aug; 44(16):2575-85. PubMed ID: 11472211 [TBL] [Abstract][Full Text] [Related]
12. Hydroxylated analogues of ATP-sensitive potassium channel openers belonging to the group of 6- and/or 7-substituted 3-isopropylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides: toward an improvement in sulfonylurea receptor 1 selectivity and metabolism stability. de Tullio P; Servais AC; Fillet M; Gillotin F; Somers F; Chiap P; Lebrun P; Pirotte B J Med Chem; 2011 Dec; 54(24):8353-61. PubMed ID: 22077416 [TBL] [Abstract][Full Text] [Related]
13. Effect on K(ATP) channel activation properties and tissue selectivity of the nature of the substituent in the 7- and the 3-position of 4H-1,2,4-benzothiadiazine 1,1-dioxides. Boverie S; Antoine MH; Somers F; Becker B; Sebille S; Ouedraogo R; Counerotte S; Pirotte B; Lebrun P; de Tullio P J Med Chem; 2005 May; 48(10):3492-503. PubMed ID: 15887958 [TBL] [Abstract][Full Text] [Related]
14. 3-Alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as ATP-sensitive potassium channel openers: effect of 6,7-disubstitution on potency and tissue selectivity. de Tullio P; Boverie S; Becker B; Antoine MH; Nguyen QA; Francotte P; Counerotte S; Sebille S; Pirotte B; Lebrun P J Med Chem; 2005 Jul; 48(15):4990-5000. PubMed ID: 16033278 [TBL] [Abstract][Full Text] [Related]
15. A pyridothiadiazine (BPDZ 44) as a new and potent activator of ATP-sensitive K+ channels. Pirotte B; Antoine MH; de Tullio P; Hermann M; Herchuelz A; Delarge J; Lebrun P Biochem Pharmacol; 1994 Apr; 47(8):1381-6. PubMed ID: 8185645 [TBL] [Abstract][Full Text] [Related]
16. Chloro-substituted 3-alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as ATP-sensitive potassium channel activators: impact of the position of the chlorine atom on the aromatic ring on activity and tissue selectivity. Pirotte B; de Tullio P; Nguyen QA; Somers F; Fraikin P; Florence X; Wahl P; Hansen JB; Lebrun P J Med Chem; 2010 Jan; 53(1):147-54. PubMed ID: 19919106 [TBL] [Abstract][Full Text] [Related]
17. Pyridothiadiazines as potent inhibitors of glucose-induced insulin release. Lebrun P; Antoine MH; Ouedraogo R; Herchuelz A; de Tullio P; Delarge J; Pirotte B Adv Exp Med Biol; 1997; 426():145-8. PubMed ID: 9544267 [No Abstract] [Full Text] [Related]
18. Effect on insulin release of compounds structurally related to the potassium-channel opener 7-chloro-3-isopropylamino-4H-1,2,4-benzothiadiazine 1,1-dioxide (BPDZ 73): introduction of heteroatoms on the 3-alkylamino side chain of the benzothiadiazine 1,1-dioxide ring. Boverie S; Antoine MH; de Tullio P; Somers F; Becker B; Sebille S; Lebrun P; Pirotte B J Pharm Pharmacol; 2001 Jul; 53(7):973-80. PubMed ID: 11480549 [TBL] [Abstract][Full Text] [Related]
19. Cationic and secretory effects of BPDZ 44 and diazoxide in rat pancreatic islets. Antoine MH; Pirotte B; Hermann M; de Tullio P; Delarge J; Herchuelz A; Lebrun P Experientia; 1994 Sep; 50(9):830-2. PubMed ID: 7925849 [TBL] [Abstract][Full Text] [Related]
20. Verapamil, a phenylalkylamine Ca2+ channel blocker, inhibits ATP-sensitive K+ channels in insulin-secreting cells from rats. Lebrun P; Antoine MH; Ouedraogo R; Pirotte B; Herchuelz A; Cosgrove KE; Kane C; Dunne MJ Diabetologia; 1997 Dec; 40(12):1403-10. PubMed ID: 9447947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]